Students must apply via one of the following online application forms:-
To apply for this course click Apply Now
Course starts: 18 October 2021Apply now
This course is an innovative, industry-orientated taught Masters programme offering a broad coverage of the pharmaceutical sciences with scope for developing a specialisation in pharmaceutics, pharmaceutical analysis or drug design.
In the context of current global pharmaceutical R&D, the course covers advanced pharmaceutics, pharmaceutical analysis, drug design, pharmacology, the biology of disease, proteomics and pharmacogenomics. You will also cover regulatory processes for medicines, in line with ICH guidelines. It is a direct response to employers’ search for postgraduates who have the optimum mix of theoretical and practical skills to be able to make an immediate contribution to frontline modern drug development.
The course mixes taught elements in a compact timetable with self-directed research. The topic of the project or dissertation is designed collaboratively to fit both your personal interests and the expertise of Sunderland's supportive tutors. It will involve typical industry-style problem solving perhaps even with pharmaceutical company partnership.
We have adopted a hybrid teaching approach of online and tutorial-based teaching that will be supplemented by focused on-campus seminars and laboratory practical classes in our outstanding Science Complex teaching facilities.
Your learning will also be complemented by problem-based learning activities that will ensure you are able to fully engage with your teaching and your peer-group. This hybrid learning approach will enable us to ensure that your time on campus is as safe as possible. Minimising the number of students and staff on campus will enable us to continue to provide essential skills-based sessions, whilst still adhering to Government guidance on social distancing.
We will be conducting risk assessments for all laboratory sessions and new appropriate measures will be taken, and our dedicated technical and facilities teams will be ensuring deep cleaning of each teaching space takes place before and after each scheduled session, for your safety.
We use a wide variety of teaching and learning methods which include lectures, seminars, open learning, laboratory work and group work. The Masters project may involve collaboration with a pharmaceutical or related company. Previous projects have involved collaborations with the British Pharmacopoeia and companies such as AstraZeneca, Pfizer, Helena Biosciences, ThermoScientific and Agilent Technologies.
Compared to an undergraduate course, you will find that this Masters requires a higher level of independent working and problem solving. Assessment methods include laboratory reports, oral presentations, case studies, critical reviews, examinations and the Masters project.
Some modules have prerequisites. Read more about what this means in our Help and Advice article.
Our typical offer is:
|a Canadian bachelor's degree||GPA 2.40|
|a USA bachelor's degree||GPA 2.5|
If your qualification is not listed above, please contact the Student Administration team at firstname.lastname@example.org for further advice.
Applications are welcome from holders of a good Honours degree (2:2 or above) in one of the following subject areas: pharmacology, pharmaceutical chemistry, pharmacy, biomedical sciences or a related subject. Alternative qualifications may be considered if supported by relevant experience.
If English is not your first language, please see our English language requirements.
The annual fee for this course is:
If you are unsure whether you qualify as a UK, EU or international student, find out more in our Help and Advice article.
The Skills Boost North East Discount is a 20% waiver on the full cost of course fees for postgraduate taught Masters courses for any worker who has been furloughed, has been made redundant, or is likely to be made redundant and who has a local connection to the North East region. The discount is also available to anyone with a connection to the North East who graduated in academic year 2019/20 with an undergraduate degree from any university, or who has graduated with an undergraduate degree from a university in the North East in academic year 2019/20 and has been unable to secure full-time graduate employment due to pressures of Covid-19. Read more about the discount.
Take a look at the Your Finances section to find out about the scholarships and bursaries that may be available to you
This information was correct at the time of publication.
Previous Sunderland graduates have been employed in companies such as GSK, Eisai, Reckitt Benckiser, Merck, Sharp & Dohme, Covance and Norbrook Laboratories. Given the breadth of pharmaceutical experience afforded by the course, overseas students have found particular success in regulatory, quality assurance and pharmacovigilance positions on returning to their home country. It should also be noted that the course has provided an excellent platform for graduates wishing to continue their studies through research towards a PhD.
Graduates from this course can pursue a variety of careers in the following areas: Drug Design, Pharmaceutical Analysis and Research, Pre-clinical Research in Experimental and Biological Studies, Formulation and Product Development, Pharmacogenomics and Proteomics, Clinical Research, Product Registration, Licensing and Regulatory Affairs.
Sign up to receive emails about your subject area.
Using Your Personal Information
The University of Sunderland is collecting this data in order for you to receive information on your chosen subject(s). Your information will be stored securely in our Customer Relationship Management system which is provided by a 3rd party and used only for the administration and provision of this information. Should you choose to opt in to further communications we will also use your information to facilitate other useful marketing information based on your preferences. Further information on how your data is stored and used can be found in our Privacy notice - marketing.